Medinex Ltd
SGX:OTX
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| SG |
M
|
Medinex Ltd
SGX:OTX
|
30.8m SGD |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
99.4B USD |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
77.6B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
64.6B EUR |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
28.4B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
24.2B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.4B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.8B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.9B EUR |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
13.2B USD |
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.2B USD |
Loading...
|
Market Distribution
| Min | -1 390 526.2% |
| 30th Percentile | 14.7% |
| Median | 28.1% |
| 70th Percentile | 43.4% |
| Max | 515 258.2% |
Other Profitability Ratios
Medinex Ltd
Glance View
Medinex Ltd. is an investment holding company, which engages in the provision of business and management consultancy services to the medical sector. The firm specializes in providing professional support services to medical clinics. The firm operates through four segments: Medical support services, Business support services, Pharmaceutical services and Medical services. Its Medical support services segment provides professional services to clients in primary and secondary healthcare sectors comprising general practitioners and specialists. Business support services segment provides professional services to customer base who are outside of healthcare industry. Its Pharmaceutical services segment provides distribution of medical and pharmaceutical products to clinics located in Singapore. Its Medical services segment provides x-rays, pre-employment check-ups and health screening in clinics located in Singapore. Its subsidiaries include Medinex Corporate Services Pte. Ltd., Medinex Healthcare Services Pte. Ltd. and Nex Healthcare Pte. Ltd.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Medinex Ltd is 77.9%, which is above its 3-year median of 76.4%.
Over the last 3 years, Medinex Ltd’s Gross Margin has increased from 72.1% to 77.9%. During this period, it reached a low of 72.1% on Sep 30, 2022 and a high of 77.9% on Sep 30, 2025.